JP7244905B2 - Organocatalysts for highly stereoselective asymmetric aldol reactions and their applications - Google Patents

Organocatalysts for highly stereoselective asymmetric aldol reactions and their applications Download PDF

Info

Publication number
JP7244905B2
JP7244905B2 JP2019032112A JP2019032112A JP7244905B2 JP 7244905 B2 JP7244905 B2 JP 7244905B2 JP 2019032112 A JP2019032112 A JP 2019032112A JP 2019032112 A JP2019032112 A JP 2019032112A JP 7244905 B2 JP7244905 B2 JP 7244905B2
Authority
JP
Japan
Prior art keywords
group
fluorous
mmol
proline
aldol reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019032112A
Other languages
Japanese (ja)
Other versions
JP2020131172A (en
Inventor
真人 松儀
佑基 小林
稿太朗 石原
優樹 渡辺
里帆 大林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meijo University
Original Assignee
Meijo University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meijo University filed Critical Meijo University
Priority to JP2019032112A priority Critical patent/JP7244905B2/en
Publication of JP2020131172A publication Critical patent/JP2020131172A/en
Application granted granted Critical
Publication of JP7244905B2 publication Critical patent/JP7244905B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Description

特許法第30条第2項適用 平成30年3月5日掲載、ウェブサイトのアドレス http://www.jsbba.or.jp/MeetingofJSBBA/2018/meeting_of_jsbba_2018.html http://www.jsbba.or.jp/MeetingofJSBBA/2018/MeetingofJSBBA2018.pdf 〔刊行物等〕 平成30年3月16日開催、日本農芸化学会、2018年度大会 名城大学 天白キャンパス(愛知県名古屋市天白区塩釜口1-501) 〔刊行物等〕 平成30年9月21日発行、フルオラス科学研究会第11回シンポジウム 予稿集、第19頁、公益財団法人野口研究所 〔刊行物等〕 平成30年9月21日開催、フルオラス科学研究会第11回シンポジウム 広島市立大学サテライトキャンパス(広島県広島市中央区大手町4丁目1番10号 大手町平和ビル9階)Article 30, Paragraph 2 of the Patent Act applied Posted on March 5, 2018, website address http://www. jsbba. or. jp/MeetingofJSBBA/2018/meeting_of_jsbba_2018. html http://www. jsbba. or. jp/MeetingofJSBBA/2018/MeetingofJSBBA2018. pdf [Publications, etc.] March 16, 2018, Japan Society for Bioscience, Biotechnology, and Agrochemistry, 2018 Annual Meeting Meijo University Tenpaku Campus (1-501 Shiogamaguchi, Tenpaku-ku, Nagoya, Aichi) [Publications, etc.] September 21, 2018 Published in Japan, The 11th Symposium of the Society for Fluorous Science, Proceedings, Page 19, Noguchi Research Institute [Publications] September 21, 2018, The 11th Symposium of the Society for Fluorous Science, Hiroshima City University Satellite Campus (9th floor, Otemachi Peace Building, 4-1-10 Otemachi, Chuo-ku, Hiroshima City, Hiroshima Prefecture)

本明細書は、プロリンを利用した高立体選択的不斉アルドール反応のための有機分子触媒及びその利用に関する。 The present specification relates to an organomolecular catalyst for a highly stereoselective asymmetric aldol reaction using proline and its use.

天然プロリンを触媒として用いた分子間不斉アルドール反応が報告されて以来(非特許文献1)、プロリンを用いた触媒は、天然に豊富に存在するアミノ酸由来の不斉原を用いた触媒として注目され、その後、様々な有機分子触媒が開発されてきている。 Since the intermolecular asymmetric aldol reaction using natural proline as a catalyst was reported (Non-Patent Document 1), catalysts using proline have attracted attention as catalysts using chiral elements derived from naturally abundant amino acids. Since then, various organomolecular catalysts have been developed.

例えば、プロリンの4位を嵩高くしたり、2位のカルボキシ基をスルホンアミド基に変換することで、高エナンチオ面選択性が得られることが報告されている(非特許文献2,3)。また、プロリンの4位に酸素を介してペルフルオロアルキル基を導入したプロリン触媒による不斉アルドール反応も報告されている(非特許文献4)。また、プロリン触媒の2位をジトリフルオロメチルベンゼンスルホンアミド型としたプロリン触媒も報告されている(非特許文献5)。 For example, it has been reported that high enantioselectivity can be obtained by making the 4-position of proline bulky or by converting the 2-position carboxy group into a sulfonamide group (Non-Patent Documents 2 and 3). In addition, an asymmetric aldol reaction using a proline catalyst in which a perfluoroalkyl group is introduced at the 4-position of proline via oxygen has also been reported (Non-Patent Document 4). A proline catalyst having a ditrifluoromethylbenzenesulfonamide type at the 2-position of the proline catalyst has also been reported (Non-Patent Document 5).

B. List, R. A. Lerner, C. F. Barbas, J. Am. Chem. Soc.2000, 122, 2395-2396.B. List, R. A. Lerner, C. F. Barbas, J. Am. Chem. Soc.2000, 122, 2395-2396. Y. Hayashi, T. Sumiya, J. Takahashi, H. Gotoh, T. Urushima, M. Shoji, Angew. Chem. Int. Ed. 2006, 45, 958-961.Y. Hayashi, T. Sumiya, J. Takahashi, H. Gotoh, T. Urushima, M. Shoji, Angew. Chem. Int. Ed. 2006, 45, 958-961. A. Berkessel, B. Koch, J. Lex, Adv. Synth. Catal. 2004, 346, 1141-1146.A. Berkessel, B. Koch, J. Lex, Adv. Synth. Catal. 2004, 346, 1141-1146. F. Fache, O. Piva, Tetrahedron: Asymmetry 2003, 14, 139-143.F. Fache, O. Piva, Tetrahedron: Asymmetry 2003, 14, 139-143. M. Kinsella, P. G. Duggan, C. M. Lennon, Tetrahedron: Asymmetry 2011, 22, 1423-1433.M. Kinsella, P. G. Duggan, C. M. Lennon, Tetrahedron: Asymmetry 2011, 22, 1423-1433.

しかしながら、既に報告されているいずれのプロリン触媒も、アルドール反応におけるエナンチオ面選択性は未だ十分ではなかった。 However, none of the previously reported proline catalysts has sufficient enantioselectivity in the aldol reaction.

本明細書は、アルドール反応において高いエナンチオ面選択性を達成できるプロリン触媒及びその利用を提供する。 The present specification provides a proline catalyst capable of achieving high enantioselectivity in an aldol reaction and its utilization.

本発明者らは、プロリンのピロリジン骨格の4位にフルオラスタグを導入するとともに、2位にもフルオラスタグを導入したところ、不斉アルドール反応において高エナンチオ面選択性を達成できるという知見を得た。本明細書は、当該知見に基づき以下の手段を提供する。 The present inventors have discovered that by introducing a fluorous tag into the 4-position of the pyrrolidine skeleton of proline and introducing a fluorous tag into the 2-position as well, high enantioselectivity can be achieved in the asymmetric aldol reaction. . This specification provides the following means based on the said knowledge.

[1]以下の式(1)で表されるプロリン誘導体若しくはその鏡像体であるプロリン誘導体又はその塩である、有機分子触媒。

Figure 0007244905000001
(R1は、第1のフルオラス基又は炭化水素基を有する第1の置換基を表し、R2は、第2のフルオラス基を有する第2の置換基を表す。)
[2]前記第1のフルオラス基は、炭素数が4~16のポリフルオロオロアルキル基である、[1]に記載の有機分子触媒。
[3]前記ポリフルオロアルキル基は、パーフルオロアルキル基である、[2]に記載の有機分子触媒。
[4]前記第1の置換基は、アルキレン基を介して、ピロリジン骨格の4位に導入される前記第1のフルオラス基又は炭化水素基を備えている、[1]~[3]のいずれかに記載の有機分子触媒。
[5]前記第2のフルオラス基は、炭素数1~4のポリフルオロアルキル基である、[1]~[4]のいずれかに記載の有機分子触媒。
[6]前記ポリフルオロアルキル基は、パーフルオロアルキル基である、[5]に記載の有機分子触媒。
[7]前記第2の置換基は、ピロリジン骨格の2位の炭素原子に結合するカルボニル炭素に結合する窒素原子を含むスルホンアミド部分を介して前記第2のフルオラス基を備える、[1]~[6]のいずれかに記載の有機分子触媒。
[8][1]~[7]のいずれかに記載の有機分子触媒を用いて、α水素を有するカルボニル化合物とケトン又はアルデヒドとのアルドール反応を行ってβ-ヒドロキシ化合物を合成する工程を備える、β-ヒドロキシ化合物製造方法。
[9]前記α水素を有するカルボニル化合物は、ニトロ基を有する、[7]又は[8]に記載の製造方法。 [1] An organic molecular catalyst which is a proline derivative represented by the following formula (1), a proline derivative which is an enantiomer thereof, or a salt thereof.
Figure 0007244905000001
(R 1 represents a first substituent having a first fluorous group or a hydrocarbon group, and R 2 represents a second substituent having a second fluorous group.)
[2] The organic molecular catalyst according to [1], wherein the first fluorous group is a polyfluorooroalkyl group having 4 to 16 carbon atoms.
[3] The organic molecular catalyst according to [2], wherein the polyfluoroalkyl group is a perfluoroalkyl group.
[4] Any one of [1] to [3], wherein the first substituent comprises the first fluorous group or hydrocarbon group introduced at the 4-position of the pyrrolidine skeleton via an alkylene group. The organic molecular catalyst according to 1.
[5] The organic molecular catalyst according to any one of [1] to [4], wherein the second fluorous group is a polyfluoroalkyl group having 1 to 4 carbon atoms.
[6] The organic molecular catalyst according to [5], wherein the polyfluoroalkyl group is a perfluoroalkyl group.
[7] The second substituent comprises the second fluorous group via a sulfonamide moiety containing a nitrogen atom bonded to the carbonyl carbon bonded to the carbon atom at the 2-position of the pyrrolidine skeleton, [1]- The organic molecular catalyst according to any one of [6].
[8] A step of synthesizing a β-hydroxy compound by performing an aldol reaction between a carbonyl compound having α hydrogen and a ketone or aldehyde using the organic molecular catalyst according to any one of [1] to [7]. , a method for producing a β-hydroxy compound.
[9] The production method according to [7] or [8], wherein the carbonyl compound having α-hydrogen has a nitro group.

本明細書の開示は、プロリンを利用した高立体選択的不斉アルドール反応のための有機分子触媒及びその利用に関する。本発明者らは、プロリンから誘導されるフルオラス有機分子触媒によって、従来にないほど不斉アルドール反応において高エナンチオ選択性を達成できることを見出した。従来、4位のみ又は2位のみにフルオラスタグを導入した触媒及び当該触媒によるアルドール反応は開示されていたが、いずれも、優れた反応生成物の立体選択性、具体的には、エナンチオ面選択性を達成することはできていなかった。本発明者らは、これら双方にフルオラスタグを導入することで、意外にも、高エナンチオ面選択性が得られることを見出した。 The present disclosure relates to organomolecular catalysts for highly stereoselective asymmetric aldol reactions utilizing proline and their use. The present inventors have found that fluorous organocatalysts derived from proline can achieve unprecedentedly high enantioselectivities in asymmetric aldol reactions. Conventionally, catalysts in which a fluorous tag is introduced only at the 4-position or only at the 2-position and aldol reactions using such catalysts have been disclosed, but both have excellent stereoselectivity of reaction products, specifically, enantioselectivity I was unable to achieve sexuality. The present inventors have unexpectedly found that by introducing a fluorous tag into both of these, high enantioselectivity can be obtained.

また、本発明者らは、これらのフルオラスタグのハロゲン含有量を設計すること(例えば、ハロゲン含有量を40%以上60%以下程度とする。)で、リサイクルも容易な固相-液相間移動型有機分子触媒が得られることも併せて見出した。以下、有機分子触媒と当該触媒を用いたアルドール反応について説明する。 In addition, the present inventors designed the halogen content of these fluorous tags (for example, the halogen content is about 40% or more and 60% or less), so that recycling is easy. It was also found that a mobile organic molecular catalyst can be obtained. An organic molecular catalyst and an aldol reaction using the catalyst will be described below.

[有機分子触媒]
本明細書において開示する有機分子触媒(以下、単に、本触媒という。)は、以下の式(1)で表されるプロリン誘導体若しくはその鏡像体であるプロリン誘導体又はその塩である。
[Organocatalyst]
The organic molecular catalyst (hereinafter simply referred to as the present catalyst) disclosed in the present specification is a proline derivative represented by the following formula (1), an enantiomer thereof, or a salt thereof.

Figure 0007244905000002
Figure 0007244905000002

すなわち、本触媒は、ピロリジン骨格の4位に第1のフルオラス基また例えば炭化水素基を含む第1の置換基「R」を備え、同2位に第2のフルオラス基を備える第2の置換基「R」を備える光学活性なプロリン誘導体又はその塩である。本触媒は、これら2つのフルオラス基(フルオラスタグ)を用いる。例えば、式(1)で示されるプロリン誘導体は、いわゆるプロリンのL体の誘導体といえ、その鏡像体はプロリンのD体の誘導体といえる。なお、本触媒は、プロリン誘導体であるが、プロリンから合成されるものに限定される趣旨ではない。 That is, the present catalyst has a first substituent "R 1 " containing a first fluorous group or, for example, a hydrocarbon group at the 4-position of the pyrrolidine skeleton, and a second substituent having a second fluorous group at the 2-position of the pyrrolidine skeleton. It is an optically active proline derivative or a salt thereof having a substituent "R 2 ". The present catalyst uses these two fluorous groups (fluorous tags). For example, the proline derivative represented by formula (1) can be said to be a so-called L-form derivative of proline, and its enantiomer can be said to be a D-form derivative of proline. Although the present catalyst is a proline derivative, it is not meant to be limited to those synthesized from proline.

第1の置換基は、ピロリジン骨格の4位の炭素原子に導入されている。第1の置換基は、第1のフルオラス基又は炭化水素基を備えることができる。 The first substituent is introduced to the 4-position carbon atom of the pyrrolidine skeleton. The first substituent can comprise a first fluorous group or a hydrocarbon group.

第1のフルオラス基は、例えば、直鎖状又は分岐状のポリフルオロアルキル基が挙げられる。直鎖状又は分岐状のポリフルオロアルキル基としては、同様のパーフルオロアルキル基が挙げられる。こうしたポリフルオロアルキル基としては、特に限定するものではないが、直鎖状である。また、ポリフルオロアルキル基は、例えば、炭素原子数が3~12個、また例えば、4~10個、また例えば、6~10個のポリフルオロアルキル基であることが好ましい。炭素原子数等の選択については、例えば、フッ素含有量に基づいて選択することができる。フルオラス含有量が、アルドール反応における高エナンチオ面選択性に影響することがわかっている。また、フルオラス含有量によって、本触媒のリサイクル性にも影響する。例えば、フッ素含有量としては40%以上60%以下程度のミディアムフルオラス含有量のフルオラス基であることが好ましい。 Examples of the first fluorous group include linear or branched polyfluoroalkyl groups. Linear or branched polyfluoroalkyl groups include similar perfluoroalkyl groups. Although such polyfluoroalkyl groups are not particularly limited, they are linear. The polyfluoroalkyl group is preferably a polyfluoroalkyl group having, for example, 3 to 12 carbon atoms, such as 4 to 10 carbon atoms, or such as 6 to 10 carbon atoms. The selection of the number of carbon atoms and the like can be made, for example, based on the fluorine content. Fluorous content has been found to influence high enantioselectivities in aldol reactions. The fluorous content also affects the recyclability of the catalyst. For example, it is preferable to use a fluorous group having a medium fluorous content of about 40% or more and 60% or less as the fluorine content.

炭化水素基は、例えば、直鎖状又は分岐状の炭化水素基であって、アルキル基、アリール基、アラルキル基等が挙げられる。こうした炭化水素基としては、特に限定するものではないが、直鎖状である。また、炭化水素基は、例えば、炭素原子数が4~18個であり、また例えば、4~16個であり、また例えば、6~14個であり、また例えば、6~12個である。炭素原子数等の選択については、特に限定するものではないが、嵩高さが高エナンチオ面選択性に影響することがわかっているので適宜選択して用いることができる。 The hydrocarbon group is, for example, a linear or branched hydrocarbon group such as an alkyl group, an aryl group, an aralkyl group, and the like. Although such hydrocarbon groups are not particularly limited, they are linear. The hydrocarbon group has, for example, 4 to 18 carbon atoms, 4 to 16 carbon atoms, 6 to 14 carbon atoms, and 6 to 12 carbon atoms. The selection of the number of carbon atoms and the like is not particularly limited, but it is known that bulkiness affects high enantioselectivity, so it can be appropriately selected and used.

第1のフルオラス基は、ピロリジン骨格の4位の炭素原子に対して直接導入されていてもよいが、連結基を介して導入されていてもよい。連結基としては、例えば、アルキレン基、アミノアルキレン基、ベンジル基など、プロリン不斉触媒に用いられる公知の連結基を適宜用いることができる。連結基は、特に限定するものではないが、例えば、炭素原子数が2~6個、また例えば、同2~4個の程度のアルキレン基を連結基とすることができる。なお、第1のフルオラス基が、パーフルオロアルキル基でないポリフルオロアルキル基の場合には、連結基部分は、完全にフルオロ化されていないアルキレン基を連結基に含めるものとする。なお、炭化水素基の場合には、連結基の一部か炭化水素基の一部かを構造からは判断できない場合もある。かかる場合においては、炭化水素基の一部に含めるものとする。 The first fluorous group may be directly introduced to the 4-position carbon atom of the pyrrolidine skeleton, or may be introduced via a linking group. As the linking group, for example, a known linking group used for proline asymmetric catalysts such as an alkylene group, an aminoalkylene group, and a benzyl group can be appropriately used. The linking group is not particularly limited, but may be, for example, an alkylene group having 2 to 6 carbon atoms, or, for example, 2 to 4 carbon atoms. When the first fluorous group is a polyfluoroalkyl group that is not a perfluoroalkyl group, the linking group portion includes an alkylene group that is not completely fluorinated. In the case of a hydrocarbon group, it may not be possible to determine from the structure whether it is part of the linking group or part of the hydrocarbon group. In such cases, it shall be included as part of the hydrocarbon group.

こうした第1のフルオラス基としては、例えば、C49基、C511基、C613基、C715基、C817基、C919基、C1021基、C1123基、C1225基等が挙げられる。また、炭化水素基としては、C613基、C715基、C817基、C919基、C1021基、C1123基、C1225、C1327基、C1429基、C1531基等が挙げられる。 Examples of such first fluorous groups include C 4 F 9 group, C 5 F 11 group, C 6 F 13 group, C 7 F 15 group, C 8 F 17 group, C 9 F 19 group, C 10 F 21 groups, C 11 F 23 groups, C 12 F 25 groups, and the like. The hydrocarbon groups include C6H13 , C7H15 , C8H17 , C9H19 , C10H21 , C11H23 , C12H25 , C 13H27 group, C14H29 group, C15H31 group and the like .

第2の置換基は、ピロリジン骨格の2位の炭素原子に導入されている。第2の置換基が備える第2のフルオラス基は、例えば、直鎖状又は分岐状のポリフルオロアルキル基が挙げられる。直鎖状又は分岐状のポリフルオロアルキル基としては、同様のパーフルオロアルキル基が挙げられる。こうしたポリフルオロアルキル基及びポリフルオロアルキレン基としては、特に限定するものではないが、直鎖状である。また、ポリフルオロアルキル基は、炭素原子数が1~6個程度、また例えば、炭素原子数が1~4個、また例えば、同1~3個,また例えば、同1~2個のポリフルオロアルキル基、また例えば、トリフルオロメチル基である。 The second substituent is introduced at the 2-position carbon atom of the pyrrolidine skeleton. Examples of the second fluorous group included in the second substituent include linear or branched polyfluoroalkyl groups. Linear or branched polyfluoroalkyl groups include similar perfluoroalkyl groups. Although such polyfluoroalkyl groups and polyfluoroalkylene groups are not particularly limited, they are linear. The polyfluoroalkyl group has about 1 to 6 carbon atoms, for example, 1 to 4 carbon atoms, for example, 1 to 3 carbon atoms, or for example, 1 to 2 polyfluoro Alkyl groups, also for example trifluoromethyl groups.

第2のフルオラス基は、1個又は2個以上を備えることができる。例えば、ベンゼン環を含むアリール基やアラルキル基の水素原子を置換するように備えられていてもよい。アリール基に対する第2のフルオラス基の導入部位は、アリール基のピロリジン骨格側への連結部位に対して、o-位、m-位及びp-位のいずれかであってもよいし2以上であってもよい。 The second fluorous group can comprise one or more. For example, it may be provided to replace a hydrogen atom of an aryl or aralkyl group containing a benzene ring. The introduction site of the second fluorous group to the aryl group may be any one of the o-position, m-position and p-position with respect to the linking site of the aryl group to the pyrrolidine skeleton side, or may be two or more. There may be.

第2の置換基の導入形態は特に限定するものではない。直接導入されていてもよいし、連結基を介して導入されていてもよい。連結基としては、例えば、アルキレン基、アミノアルキレン基、ベンジル基など、プロリン不斉触媒に用いられる公知の連結基を適宜用いることができる。例えば、第2のフルオラス基及び第2のフルオラス基を有するアリール基やアラルキル基は、ピロリジン骨格の2位の炭素原子に直接導入されていてもよいが、ピロリジン骨格の2位の炭素原子に連結されるカルボニル基スルホンアミド部分(-NHSO2-)を介して導入されていてもよい。 The introduction form of the second substituent is not particularly limited. It may be introduced directly or may be introduced via a linking group. As the linking group, for example, a known linking group used for proline asymmetric catalysts such as an alkylene group, an aminoalkylene group, and a benzyl group can be appropriately used. For example, the second fluorous group and the aryl group or aralkyl group having the second fluorous group may be directly introduced to the carbon atom at the 2-position of the pyrrolidine skeleton, but may be linked to the carbon atom at the 2-position of the pyrrolidine skeleton. may be introduced via a carbonyl group sulfonamide moiety (--NHSO 2 --).

こうした、第2のフルオラス基としては、例えば、以下の形態が挙げられる。なお、以下の形態では、ピロリジン骨格の2位のカルボニル基炭素原子に、スルホンアミド部分を連結基として導入した形態で例示する。 Examples of such a second fluorous group include the following forms. In the following embodiments, a sulfonamide moiety is introduced as a linking group to the carbon atom of the carbonyl group at the 2-position of the pyrrolidine skeleton.

Figure 0007244905000003
Figure 0007244905000003

本触媒は、プロリン誘導体内に、ピロリジン骨格におけるNHなどの塩形成可能部位を備えるため、例えば、酸と塩を形成することができる。酸としては、特に限定するものではないが、例えば、カルボン酸誘導体、硫酸又はスルホン酸誘導体、リン酸誘導体、塩酸等が挙げられる。 Since the present catalyst has a salt-forming site such as NH in the pyrrolidine skeleton in the proline derivative, it can form a salt with an acid, for example. Examples of the acid include, but are not particularly limited to, carboxylic acid derivatives, sulfuric acid or sulfonic acid derivatives, phosphoric acid derivatives, and hydrochloric acid.

[有機分子触媒の製造方法]
本触媒の製造方法は、特に限定するものではないが、公知の方法によって製造することができる。例えば、4位に水酸基を備えるのヒドロキシプロリンのNHの水素原子をベンジルオキシカルボニル基などで保護しておいた上で、4位に第1のフルオラス基又は炭化水素基を導入する。その後、この反応生成物のピロリジン骨格の2位のカルボニル基炭素に、第2のフルオラス基を備えるビストリフルオロメチルベンゼンスルホンアミドを導入するようにする。
[Method for producing organomolecular catalyst]
Although the production method of the present catalyst is not particularly limited, it can be produced by a known method. For example, after protecting the NH hydrogen atom of hydroxyproline having a hydroxyl group at the 4-position with a benzyloxycarbonyl group or the like, the first fluorous group or hydrocarbon group is introduced at the 4-position. After that, bistrifluoromethylbenzenesulfonamide having a second fluorous group is introduced to the 2-position carbonyl group carbon of the pyrrolidine skeleton of this reaction product.

[有機分子触媒を用いたアルドール反応によるβ-ヒドロキシ化合物の合成する工程を備える、β-ヒドロキシ化合物の製造方法]
本明細書に開示されるβ-ヒドロキシ化合物の製造方法は、本触媒を用いて、α水素を有するカルボニル化合物を用いてとケトン又はアルデヒドとのアルドール反応を行って、β-ヒドロキシ化合物を合成する工程を備えることができる。本方法によれば、極めて高いエナンチオ面選択性により、光学活性であるβ-ヒドロキシ化合物を製造することができる。例えば、本製造方法によれば、光学活性アンチ型β-ヒドロキシ化合物を高い選択性で合成することができる。
[Method for Producing β-Hydroxy Compound Comprising Step of Synthesizing β-Hydroxy Compound by Aldol Reaction Using Organic Molecular Catalyst]
The method for producing a β-hydroxy compound disclosed herein uses the present catalyst to synthesize a β-hydroxy compound by performing an aldol reaction with a carbonyl compound having an α hydrogen and a ketone or aldehyde. A process can be provided. According to this method, an optically active β-hydroxy compound can be produced with extremely high enantioselectivity. For example, according to this production method, an optically active anti-β-hydroxy compound can be synthesized with high selectivity.

また、本触媒によれば、水などの水性媒体ほか、THFやトルエンなどの非水混和性溶媒においても、同様に、高い選択率で光学活性β-ヒドロキシ化合物を合成することができる。また、本触媒によれば、カルボニル化合物として、ニトロ基を有する化合物、例えば、p-ニトロベンズアルデヒドなどであっても、光学活性なβ-ヒドロキシ化合物を高い選択性で合成することができる。 Moreover, according to the present catalyst, optically active β-hydroxy compounds can be synthesized with high selectivity in water-insoluble solvents such as THF and toluene as well as aqueous media such as water. Further, according to the present catalyst, even if the carbonyl compound is a compound having a nitro group, such as p-nitrobenzaldehyde, an optically active β-hydroxy compound can be synthesized with high selectivity.

本触媒によるこのような高エナンチオ面選択性は、ピロリジン骨格の4位に嵩高いフルオラス基又は炭化水素基を有しつつ、ピロリジン骨格と同2位のフルオラス基によって、安定した不斉空間が形成されるものによると考えられる。 The high enantioselectivity of this catalyst is due to the presence of a bulky fluorous group or hydrocarbon group at the 4-position of the pyrrolidine skeleton, and the formation of a stable asymmetric space by the fluorous group at the 2-position of the pyrrolidine skeleton. It is thought that it depends on what is done.

α水素を有するカルボニル化合物としては、特に限定するものではないが、種々のアルデヒド及びケトンを用いることができる。また、また、α水素を有するカルボニル化合物としては、エステルやアミドなどを用いることもできる。 The carbonyl compound having α-hydrogen is not particularly limited, but various aldehydes and ketones can be used. Esters, amides, and the like can also be used as carbonyl compounds having α-hydrogen.

以下、本明細書の開示をより具体的に説明するために具体例としての実施例を記載する。以下の実施例は、本明細書の開示を説明するためのものであって、その範囲を原知恵するものではない。 Examples are given below as specific examples in order to more specifically describe the disclosure of the present specification. The following examples are intended to illustrate the disclosure herein and are not intended to dictate its scope.

<触媒の合成>
本実施例では、ピロリジン骨格の4位にフルオラス基(C817基)及び炭化水素基(C817基)をそれぞれ有し、同2位のカルボニル基炭素原子にスルホンアミド部分を介してm-ビストリフルオロメチルベンゼンを備えるプロリン触媒(1)及び(2)と、ピロリジン骨格の4位にフルオラス基(C817基)を有し、同2位のカルボニル基炭素原子にスルホンアミド部分を介してp-トリフルオロメチルベンゼンを備えるプロリン触媒(3)を合成した。また、別途、対照として、炭化水素基を同4位に備えるが、ビスメチルベンゼンをスルホンアミド部分を介して同2位のカルボニル基炭素原子に備える対照プロリン触媒(1)と、フルオラス基を同4位に備えるが、同2位のカルボキシ基のみを備える対照プロリン触媒(2)とを合成した。
<Synthesis of catalyst>
In this example, the pyrrolidine skeleton has a fluorous group (C 8 F 17 group) and a hydrocarbon group (C 8 H 17 group) at the 4-position, respectively, and a carbonyl group carbon atom at the 2-position via a sulfonamide moiety. proline catalysts (1) and (2) comprising m-bistrifluoromethylbenzene and a pyrrolidine skeleton having a fluorous group (C 8 F 17 group) at position 4 and a sulfonamide at the carbonyl group carbon atom at position 2 of the pyrrolidine skeleton. A proline catalyst (3) was synthesized with p-trifluoromethylbenzene via a moiety. Separately, as a control, a control proline catalyst (1), which has a hydrocarbon group at the 4-position but has a bismethylbenzene at the carbonyl group carbon atom at the 2-position via a sulfonamide moiety, and a fluorous group at the same A control proline catalyst (2) was synthesized with the 4-position but only with the 2-position carboxy group.

<プロリン触媒(1)の合成>
以下に、プロリン触媒(1)の合成スキームを示し、次に、それぞれの化合物の合成方法を順追って記載する。以下、他の触媒についても同様である。
<Synthesis of proline catalyst (1)>
A synthesis scheme of proline catalyst (1) is shown below, and then the methods for synthesizing each compound are described in order. The same applies to other catalysts below.

Figure 0007244905000004
Figure 0007244905000004

(2S,4R)-1-((Benzyloxy)carbonyl)-4-hydroxypyrrolidine-2-carboxylic acidの合成
この化合物を以下の式に従って合成した。
Synthesis of (2S,4R)-1-((Benzyloxy)carbonyl)-4-hydroxypyrrolidine-2-carboxylic acid This compound was synthesized according to the following formula.

Figure 0007244905000005
Figure 0007244905000005

trans-4-Hydroxy-L-proline (1.64 g 12.6 mmol) と炭酸ナトリウム (3.33 g 31.5 mmol)をH2O(12 mL)とアセトン(2mL)の混合溶媒に溶かして10分間撹拌した。30分かけて系内にCbz-Cl (2.13 mL, 15.12 mmol) を 4 回に分けて滴下した。その後、室温で20.5時間撹拌した。反応終了後、反応液に H2O (30 mL) を加えて希釈した後、Et2O (15 mL) で 3 回洗浄した。水層を 0 °C に冷却し、6N HCl aq. をゆっくりと加えて pH 1-2 に調製した後、酢酸エチル (25 mL) で 3 回抽出した。さらに飽和食塩水 (20 mL) で 2 回洗浄し、酢酸エチル層を無水硫酸ナトリウムで脱水乾燥後、減圧濃縮した。得られた残渣をシリカゲルクロマトグラフィー (酢酸エチル : メタノール = 5 : 1) により精製した。(3.27 g, 98%)
Colorless oil; 1H NMR (270 MHz, CDCl3); δ 7.38-7.28 (m, 5H), 5.19 (d, J = 10.8 Hz, 2H), 4.64-4.54 (m, 2H), 3.66 (d, J= 18.9 Hz, 2H), 2.46-2.06 (m, 2H).
Trans-4-Hydroxy-L-proline (1.64 g 12.6 mmol) and sodium carbonate (3.33 g 31.5 mmol) were dissolved in a mixed solvent of H 2 O (12 mL) and acetone (2 mL) and stirred for 10 minutes. Over 30 minutes, Cbz-Cl (2.13 mL, 15.12 mmol) was added dropwise to the system in four portions. After that, the mixture was stirred at room temperature for 20.5 hours. After completion of the reaction, the reaction solution was diluted with H 2 O (30 mL), and then washed with Et 2 O (15 mL) three times. The aqueous layer was cooled to 0 °C, 6N HCl aq. was added slowly to adjust to pH 1-2, and then extracted with ethyl acetate (25 mL) three times. Further, the mixture was washed twice with saturated brine (20 mL), and the ethyl acetate layer was dehydrated and dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The resulting residue was purified by silica gel chromatography (ethyl acetate:methanol=5:1). (3.27g, 98%)
Colorless oil; 1 H NMR (270 MHz, CDCl 3 ); = 18.9 Hz, 2H), 2.46-2.06 (m, 2H).

(2S,4R)-4-(Allyloxy)-1-((benzyloxy)carbonyl)pyrrolidine-2-carboxylic acidの合成 Synthesis of (2S,4R)-4-(Allyloxy)-1-((benzyloxy)carbonyl)pyrrolidine-2-carboxylic acid

Figure 0007244905000006
Figure 0007244905000006

三ツ口フラスコに (2S,4R)-1-((benzyloxy)carbonyl)-4-hydroxypyrrolidine-2-carboxylic acid (2.1 g, 7.9 mmol) を量りとり、窒素置換した後に dry-THF (20 mL) を加えた。系内を 0 °C まで冷却した後、水素化ナトリウム (792 mg, 19.8 mmol) を 3 回に分けて加え、室温まで昇温して 15 分攪拌した。系内に臭化アリル (1.8 mL, 20.6 mmol) を滴下した後、還流条件下で 41 時間撹拌した。反応終了後、H2O (17 mL) を加え、さらに 1N HCl aq. を用いて系内を pH 1-2 に調製した後、酢酸エチルで 3 回抽出した。有機層を飽和食塩水で 3 回洗浄し、無水硫酸ナトリウムで脱水乾燥後、減圧濃縮した。得られた残渣に NaOH (511 mg, 12.9 mmol)、H2O (3 mL)、および MeOH (3 mL) を加え、室温で 24 時間撹拌した。反応終了後、反応液を水で希釈し、酢酸エチルで 3 回洗浄した。水層を 1N HCl aq. を用いて pH 1-2 に調製した後、酢酸エチルで 3 回抽出した。有機層を飽和食塩水で 3 回洗浄し、無水硫酸ナトリウムで脱水乾燥後、減圧濃縮を行った。(1.66 g, 69%)
Colorless oil; 1H NMR (270 MHz, CDCl3); δ 7.29-7.26 (m, 5H), 5.92-5.81 (m, 1H), 5.92-5.11 (m, 2H), 4.52-4.48 (m, 1H), 4.17 (m, 1H), 3.97-3.96 (m, 2H), 3.75-3.61 (m, 2H), 2.44-2.04 (m, 2H).
Weigh (2S,4R)-1-((benzyloxy)carbonyl)-4-hydroxypyrrolidine-2-carboxylic acid (2.1 g, 7.9 mmol) into a three-necked flask, replace with nitrogen, and add dry-THF (20 mL). rice field. After cooling the inside of the system to 0°C, sodium hydride (792 mg, 19.8 mmol) was added in three portions, and the mixture was warmed to room temperature and stirred for 15 minutes. After allyl bromide (1.8 mL, 20.6 mmol) was added dropwise into the system, the mixture was stirred under reflux conditions for 41 hours. After completion of the reaction, H 2 O (17 mL) was added, and the pH of the system was adjusted to 1-2 using 1N HCl aq., followed by extraction with ethyl acetate three times. The organic layer was washed with saturated brine three times, dehydrated and dried over anhydrous sodium sulfate, and concentrated under reduced pressure. NaOH (511 mg, 12.9 mmol), H 2 O (3 mL) and MeOH (3 mL) were added to the resulting residue and stirred at room temperature for 24 hours. After completion of the reaction, the reaction solution was diluted with water and washed with ethyl acetate three times. The aqueous layer was adjusted to pH 1-2 using 1N HCl aq. and extracted three times with ethyl acetate. The organic layer was washed with saturated brine three times, dehydrated and dried over anhydrous sodium sulfate, and concentrated under reduced pressure. (1.66g, 69%)
Colorless oil; 1 H NMR (270 MHz, CDCl 3 ); , 4.17 (m, 1H), 3.97-3.96 (m, 2H), 3.75-3.61 (m, 2H), 2.44-2.04 (m, 2H).

(2S,4R)-1-((Benzyloxy)carbonyl)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-iodoundecyl)oxy)pyrrolidine-2-carboxylic acidの合成 (2S,4R)-1-((Benzyloxy)carbonyl)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11 Synthesis of ,11-heptadecafluoro-2-iodoundecyl)oxy)pyrrolidine-2-carboxylic acid

Figure 0007244905000007
Figure 0007244905000007

N2 雰囲気下 -78 °C で (2S,4R)-4-(allyloxy)-1-((benzyloxy)carbonyl)pyrrolidine-2-carboxylic acid (3.85 g, 13 mmol) を脱気した後、室温で C8F17I (3.43 mL, 13 mmol) を加え、80 °C に昇温した。系内に AIBN (210 mg, 1.3 mmol) を加え、43 時間撹拌した。反応終了後、1N HCl aq. を用いて pH 1-2 に調製した後、酢酸エチルで 3 回抽出した。有機層を飽和食塩水で 3 回洗浄し、無水硫酸ナトリウムで脱水乾燥後、減圧濃縮した。得られた残渣を FSPE (メタノール : 水 = 68 : 32) によって精製した。(4.85 g, 43%)
Yellow oil; 1H NMR (270 MHz, CDCl3); δ 7.36-7.26 (m, 5H), 5.25-5.14 (m, 2H), 4.59-4.48 (m, 1H), 4.37-4.30 (m, 1H), 4.30-4.17 (m, 1H), 3.76-3.54 (m, 4H), 2.99-2.65 (m, 2H), 2.47-2.18 (m, 2H); 13C NMR (125 MHz, CDCl3); δ 176.28, 174.79, 155.98, 154.62, 136.36, 136.09, 128.62, 128.46, 118.37-108.49, 73.76, 67.85, 67.40, 58.21-57.65, 37.70, -34.99, 14.25; 19F NMR (466 MHz, CDCl3); δ, -125.96 (2F), -123.35 (2F), -122.56 (2F), -121.74 (4F), -121.41 (2F), -114.29--112.39 (2F), -80.61 (3F); HRMS (FAB+) m/z calcd for C24H20O5NF17I 852.0115, found: 852.0133.
After degassing (2S,4R)-4-(allyloxy)-1-((benzyloxy)carbonyl)pyrrolidine-2-carboxylic acid (3.85 g, 13 mmol) at -78 °C under N 2 atmosphere, C8F17I (3.43 mL, 13 mmol) was added and the temperature was raised to 80° C . AIBN (210 mg, 1.3 mmol) was added to the system and stirred for 43 hours. After completion of the reaction, the pH was adjusted to 1-2 using 1N HCl aq., and extracted with ethyl acetate three times. The organic layer was washed with saturated brine three times, dehydrated and dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The obtained residue was purified by FSPE (methanol:water=68:32). (4.85g, 43%)
Yellow oil; 1 H NMR (270 MHz, CDCl 3 ); , 4.30-4.17 (m, 1H), 3.76-3.54 (m, 4H), 2.99-2.65 (m, 2H), 2.47-2.18 (m, 2H); 13 C NMR (125 MHz, CDCl 3 ); , 174.79 , 155.98, 154.62, 136.09, 136.09, 128.62, 128.46, 118.37-108.49, 73.76, 67.40 , 67.40, 58.21-57.65, -34.99 125.96 (2F), -123.35 (2F), -122.56 (2F), -121.74 (4F), -121.41 (2F), -114.29--112.39 (2F), -80.61 (3F); z calcd for C24H20O5NF17I 852.0115 , found : 852.0133.

(2S,4R)-1-((Benzyloxy)carbonyl)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecyl)oxy)pyrrolidine-2-carboxylic acidの合成 (2S,4R)-1-((Benzyloxy)carbonyl)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11 Synthesis of ,11-heptadecafluoroundecyl)oxy)pyrrolidine-2-carboxylic acid

Figure 0007244905000008
Figure 0007244905000008

(2S,4R)-1-((Benzyloxy)carbonyl)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-iodoundecyl)oxy)pyrrolidine-2-carboxylic acid (652.5 mg, 0.766 mmol) をエタノール (10 mL) に溶かした後、AIBN (12.6 mg, 0.0766 mmol)、次亜リン酸 (1.44 mL, 7.66 mmol)、炭酸水素ナトリウム (772.8 mg, 9.19 mmol) の順に加え、還流条件下で 4 時間撹拌した。反応終了後、1N HCl aq. を用いて系内を pH 1-2 に調製した後、酢酸エチルで 3 回抽出を行った。有機層を飽和食塩水で 3 回洗浄し、無水硫酸ナトリウムで脱水乾燥後、減圧濃縮した。得られた残渣をカラムクロマトグラフィー (ジクロロメタン : メタノール = 15 : 1) によって精製した。(348.7 mg, 63%)
Yellow oil; 1H NMR (270 MHz, CDCl3); δ 7.31-7.29 (m, 5H), 5.22-5.08 (m, 2H), 4.49-4.39 (m, 1H), 4.09 (t, J = 3.3 Hz, 1H), 3.71-3.46 (m, 4H), 2.25-2.08 (m, 4H), 1.85-1.61 (m, 2H).
(2S,4R)-1-((Benzyloxy)carbonyl)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11 AIBN (12.6 mg, 0.0766 mmol), hypophosphorous acid (1.44 mL, 7.66 mmol) and sodium bicarbonate (772.8 mg, 9.19 mmol) were added in that order, and the mixture was stirred under reflux for 4 hours. After completion of the reaction, the system was adjusted to pH 1-2 using 1N HCl aq., and extracted three times with ethyl acetate. The organic layer was washed with saturated brine three times, dehydrated and dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The resulting residue was purified by column chromatography (dichloromethane:methanol=15:1). (348.7mg, 63%)
Yellow oil; 1 H NMR (270 MHz, CDCl 3 ); , 1H), 3.71-3.46 (m, 4H), 2.25-2.08 (m, 4H), 1.85-1.61 (m, 2H).

3,5-Bis(trifluoromethyl)benzenesulfonamideの合成 Synthesis of 3,5-Bis(trifluoromethyl)benzenesulfonamide

Figure 0007244905000009
Figure 0007244905000009

3,5- Bis(trifluoromethyl)benzenesulfonyl chloride (2.0 g, 6.4 mmol) をH2O (10 mL) に溶かした後、25% アンモニア水 (2.5 mL, 33.4 mmol) を加えて、100 °C で 2 時間撹拌した。減圧濃縮した後、得られた粗生成物に 1N HCl aq. を加え、生じた沈殿物を吸引ろ過により回収した。(1.6 g, 85%)
White solid; m.p. 182-183 °C; 1H NMR (270 MHz, CDCl3); δ 8.39 (s, 2H), 8.09 (s, 1H), 5.00 (s, 2H).
3,5-Bis(trifluoromethyl)benzenesulfonyl chloride (2.0 g, 6.4 mmol) was dissolved in H 2 O (10 mL), 25% aqueous ammonia (2.5 mL, 33.4 mmol) was added, and the mixture was stirred at 100 °C for 2 hours. Stirred for an hour. After concentration under reduced pressure, 1N HCl aq. was added to the resulting crude product, and the resulting precipitate was collected by suction filtration. (1.6g, 85%)
White solid; mp 182-183 °C; 1 H NMR (270 MHz, CDCl 3 ); δ 8.39 (s, 2H), 8.09 (s, 1H), 5.00 (s, 2H).

Benzyl(2S,4R)-2-(((3,5-bis(trifluoromethyl)phenyl)sulfonyl)carbamoyl)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecyl)oxy)pyrrolidine-1-carboxylateの合成 Benzyl(2S,4R)-2-(((3,5-bis(trifluoromethyl)phenyl)sulfonyl)carbamoyl)-4-((4,4,5,5,6,6,7,7,8,8 Synthesis of ,9,9,10,10,11,11,11-heptadecafluoroundecyl)oxy)pyrrolidine-1-carboxylate

Figure 0007244905000010
Figure 0007244905000010

N2 雰囲気下にて、(2S,4R)-1-((benzyloxy)carbonyl)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecyl)oxy)pyrrolidine-2-carboxylic acid (348.8 mg, 0.48 mmol)、3,5-bis(trifluoromethyl)benzenesulfonamide (209.8 mg, 0.72 mmol)、DMAP (19.6 mg, 0.12 mmol)、および HOBt (110 mg, 0.72 mmol) を dry-CH2Cl2(10 mL) と dry-DMF (5 mL) の混合溶媒に溶かした。系内を 0 °C に冷却した後、EDCI (127 mL, 0.72 mmol) を滴下し、10 分間撹拌した。さらに室温で 32 時間撹拌した。反応終了後、1N HCl aq. を用いて系内を pH 1-2 に調製した後、酢酸エチルで 3 回抽出を行った。有機層を飽和食塩水で 3 回洗浄し、無水硫酸ナトリウムで脱水乾燥後、減圧濃縮した。得られた残渣をカラムクロマトグラフィー (ヘキサン : 酢酸エチル = 4 : 1) によって精製した。(400.8 mg, 83%)
Yellow oil; 1H NMR (270 MHz, CDCl3); δ 8.46 (s, 2H), 7.99 (s, 1H), 7.46-7.29 (m, 5H), 5.28-5.00 (m, 2H), 4.40 (s, 1H), 4.04 (s, 1H), 3.54-3.39 (m, 4H), 2.07-1.76 (m, 4H), 1.25-1.22 (m, 2H); 13C NMR (125 MHz, CDCl3); δ 135.49, 132.62-121.46, 118.53-108.00, 68.59, 67.76, 51.64, 27.82, 27.29, 20.91; 19F NMR (466 MHz, CDCl3); δ -125.73--126.58 (2F), -123.10--123.70 (2F), -122.44--122.98 (2F), -121.15--122.35 (6F), -113.92--114.84 (2F), -80.56--80.89 (3F), -62.40--3.58 (6F); HRMS (FAB+) m/z calcd for C32H24O6N2F23S 1001.0988, found: 1001.0948.
( 2S ,4R)-1-((benzyloxy)carbonyl)-4-((4,4,5,5,6,6,7,7,8,8,9,9, 10,10,11,11,11-heptadecafluoroundecyl)oxy)pyrrolidine-2-carboxylic acid (348.8 mg, 0.48 mmol), 3,5-bis(trifluoromethyl)benzenesulfonamide (209.8 mg, 0.72 mmol), DMAP (19.6 mg, 0.12 mmol), and HOBt (110 mg, 0.72 mmol) were dissolved in a mixed solvent of dry-CH 2 Cl 2 (10 mL) and dry-DMF (5 mL). After cooling the inside of the system to 0 °C, EDCI (127 mL, 0.72 mmol) was added dropwise and stirred for 10 minutes. Further, the mixture was stirred at room temperature for 32 hours. After completion of the reaction, the system was adjusted to pH 1-2 using 1N HCl aq., and extracted three times with ethyl acetate. The organic layer was washed with saturated brine three times, dehydrated and dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The resulting residue was purified by column chromatography (hexane:ethyl acetate=4:1). (400.8 mg, 83%)
Yellow oil; 1 H NMR (270 MHz, CDCl 3 ); , 1H), 4.04 (s, 1H), 3.54-3.39 (m, 4H), 2.07-1.76 (m, 4H), 1.25-1.22 (m, 2H); 13 C NMR (125 MHz, CDCl 3 ); 135.49, 132.62-121.46, 118.53-108.00, 68.59, 67.76, 51.64, 27.82, 27.29, 20.91; 19 F NMR (466 MHz, CDCl3 ); ), -122.44--122.98 (2F), -121.15--122.35 (6F), -113.92--114.84 (2F), -80.56--80.89 (3F), -62.40--3.58 (6F); ) m/z calcd for C32H24O6N2F23S 1001.0988 , found: 1001.0948 .

(2S,4R)-N-((3,5-Bis(trifluoromethyl)phenyl)sulfonyl)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecyl)oxy)pyrrolidine-2-carboxamideの合成 (2S,4R)-N-((3,5-Bis(trifluoromethyl)phenyl)sulfonyl)-4-((4,4,5,5,6,6,7,7,8,8,9,9 Synthesis of ,10,10,11,11,11-heptadecafluoroundecyl)oxy)pyrrolidine-2-carboxamide

Figure 0007244905000011
Figure 0007244905000011

Benzyl(2S,4R)-2-(((3,5-bis(trifluoromethyl)phenyl)sulfonyl)carbamoyl)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecyl)oxy)pyrrolidine-1-carboxylate (379.0 mg, 0.38 mmol) を MeOH (6 mL) に溶かし、5% 担持 Pd/C (161.76 mg, 0.076 mmol) を加えた後、H2 置換して室温で 17 時間撹拌した。MeOH を用いてセライトろ過を行い、濾液を減圧濃縮した。得られた残渣をカラムクロマトグラフィー (ジクロロメタン : メタノール = 19 : 1) によって精製した。(286.3 mg, 88%)
Yellow solid; m.p. 103.8-104.9 °C; 1H NMR (270 MHz, CDCl3); δ 8.39 (s, 2H), 7.99 (s, 1H), 4.51 (m, 1H), 4.20 (s, 1H), 3.62-3.46 (m, 4H), 2.59 (m, 1H), 2.18-2.02 (m, 3H), 1.85-1.71 (m, 2H); 13C NMR (125 MHz, CDCl3); δ 173.17, 146.40, 131.56-124.56, 77.88, 67.12, 61.10, 50.86, 35.09, 27.23, 20.36; 19F NMR (466 MHz, CDCl3); δ -127.19 (2F), -124.33 (2F), -123.65 (2F), -122.44--123.01 (6F), -115.33 (2F), -82.28 (3F), -64.32 (5F); HRMS (FAB+) m/z calcd for C24H18O4N2F23S 867.0620, found: 867.0625.
Benzyl(2S,4R)-2-(((3,5-bis(trifluoromethyl)phenyl)sulfonyl)carbamoyl)-4-((4,4,5,5,6,6,7,7,8,8 ,9,9,10,10,11,11,11-heptadecafluoroundecyl)oxy)pyrrolidine-1-carboxylate (379.0 mg, 0.38 mmol) was dissolved in MeOH (6 mL) and 5% supported Pd/C (161.76 mg, 0.076 mmol) was added, and the mixture was replaced with H 2 and stirred at room temperature for 17 hours. Celite filtration was performed using MeOH, and the filtrate was concentrated under reduced pressure. The resulting residue was purified by column chromatography (dichloromethane:methanol=19:1). (286.3mg, 88%)
Yellow solid; mp 103.8-104.9 °C; 1 H NMR (270 MHz, CDCl 3 ); 3.62-3.46 (m, 4H), 2.59 (m, 1H), 2.18-2.02 (m, 3H), 1.85-1.71 (m, 2H); 13 C NMR (125 MHz, CDCl 3 ); δ 173.17, 146.40, 131.56-124.56, 77.88, 67.12, 61.10, 50.86 , 35.09, 27.23, 20.36; 19 F NMR (466 MHz, CDCl3); --123.01 (6F), -115.33 (2F), -82.28 ( 3F ), -64.32 (5F); HRMS (FAB+ ) m/z calcd for C24H18O4N2F23S 867.0620, found: 867.0625 .

<プロリン触媒(2)の合成>
以下に、プロリン触媒(1)の合成スキームを示し、次に、それぞれの化合物の合成方法を順追って記載する。
<Synthesis of proline catalyst (2)>
A synthesis scheme of proline catalyst (1) is shown below, and then the methods for synthesizing each compound are described in order.

Figure 0007244905000012
Figure 0007244905000012

(2S,4R)-1-((Benzyloxy)carbonyl)-4-(undecyloxy)pyrrolidine-2-carboxylic acidの合成

Figure 0007244905000013
Synthesis of (2S,4R)-1-((Benzyloxy)carbonyl)-4-(undecyloxy)pyrrolidine-2-carboxylic acid
Figure 0007244905000013

三ツ口フラスコに (2S,4R)-1-((benzyloxy)carbonyl)-4-hydroxypyrrolidine-2-carboxylic acid (999.6 mg, 3.8 mmol) を量りとり、窒素置換した後に dry-DMF (10 mL) を加えた。系内を 0 °C まで冷却した後、水素化ナトリウム (565.5 mg, 9.4 mmol) を 2 回に分けて加え、室温まで昇温して 15 分間攪拌した。系内に 1-ヨードウンデカン (2.2 mL, 9.8 mmol) を滴下した後、還流条件下で 4 日間撹拌した。反応終了後、H2O を加え、さらに 1N HCl aq. を用いて系内を pH 1-2 に調製した後、酢酸エチルで 3 回抽出した。有機層を飽和食塩水で 3 回洗浄し、無水硫酸ナトリウムで脱水乾燥後、減圧濃縮した。得られた残渣をカラムクロマトグラフィー (酢酸エチル : メタノール = 20 : 1) によって精製した。(1238.3 mg, 78%)
Yellow Oil; 1H NMR (270MHz, CDCl3) δ = 7.36 (s, 5H), 5.12-5.19 (s, 2H), 4.49-4.55 (s, 1H), 4.06-4.14 (s,1H), 3.57-3.67 (m, 2H), 3.38-3.43 (m, 2H), 2.05-2.38 (m, 2H), 1.52 (s, 2H), 1.26 (s, 16H), 0.85 (t, J = 7.0 Hz, 3H).
(2S,4R)-1-((benzyloxy)carbonyl)-4-hydroxypyrrolidine-2-carboxylic acid (999.6 mg, 3.8 mmol) was weighed into a three-necked flask, purged with nitrogen, and dry-DMF (10 mL) was added. rice field. After cooling the inside of the system to 0°C, sodium hydride (565.5 mg, 9.4 mmol) was added in two portions, the temperature was raised to room temperature, and the mixture was stirred for 15 minutes. After 1-iodoundecane (2.2 mL, 9.8 mmol) was added dropwise into the system, the mixture was stirred under reflux conditions for 4 days. After completion of the reaction, H 2 O was added, and the pH of the system was adjusted to 1-2 using 1N HCl aq., followed by extraction with ethyl acetate three times. The organic layer was washed with saturated brine three times, dehydrated and dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The resulting residue was purified by column chromatography (ethyl acetate:methanol=20:1). (1238.3 mg, 78%)
Yellow Oil; 1 H NMR (270MHz, CDCl 3 ) δ = 7.36 (s, 5H), 5.12-5.19 (s, 2H), 4.49-4.55 (s, 1H), 4.06-4.14 (s,1H), 3.57- 3.67 (m, 2H), 3.38-3.43 (m, 2H), 2.05-2.38 (m, 2H), 1.52 (s, 2H), 1.26 (s, 16H), 0.85 (t, J = 7.0Hz, 3H) .

Benzyl (2S,4R)-2-(((3,5-bis(trifluoromethyl)phenyl)sulfonyl)carbamoyl)-4-(undecyloxy)pyrrolidine-1-carboxylateの合成 Synthesis of Benzyl (2S,4R)-2-(((3,5-bis(trifluoromethyl)phenyl)sulfonyl)carbamoyl)-4-(undecyloxy)pyrrolidine-1-carboxylate

Figure 0007244905000014
Figure 0007244905000014

N2 雰囲気下にて、(2S,4R)-1-((benzyloxy)carbonyl)-4-(undecyloxy)pyrrolidine-2-carboxylic acid (303.3 mg, 0.72 mmol)、3,5-bis(trifluoromethyl)benzenesulfonamide (313.2 mg, 1.07 mmol)、DMAP (29.1 mg, 0.18 mmol)、および HOBt (163.1 mg, 1.07 mmol) を dry-CH2Cl2(10 mL) と dry-DMF (5 mL) の混合溶媒に溶かした。系内を 0 °C に冷却した後、EDCI (148 μL, 1.07 mmol) を滴下し、20 分間撹拌した。さらに室温で 28 時間撹拌した。反応終了後、1N HCl aq. を用いて系内を pH 1-2 に調製した後、酢酸エチルで 3 回抽出を行った。有機層を飽和食塩水で 3 回洗浄し、無水硫酸ナトリウムで脱水乾燥後、減圧濃縮した。得られた残渣をカラムクロマトグラフィー (ヘキサン : 酢酸エチル = 3 : 1) によって精製した。(63.9 mg, 64%)
Yellow Oil; 1H NMR (270MHz, CDCl3) δ = 8.53 (s,2H), 8.11(s, 1H), 7.34(s, 5H), 5.11-5.22 (s, 2H), 4.37-4.42 (m, 1H), 3.99-4.04 (m, 1H), 3.59-3.64 (m, 2H), 3.29-3.48 (m, 2H), 2.37-2.46 (m, 1H), 2.03-2.17 (m, 1H), 1.46-1.51 (t, 2H), 1.25 (s, 16H), 0.85 (t, J = 7.0 Hz, 3H).
(2S,4R)-1-((benzyloxy)carbonyl) -4- (undecyloxy)pyrrolidine-2-carboxylic acid (303.3 mg, 0.72 mmol), 3,5-bis(trifluoromethyl)benzenesulfonamide (313.2 mg, 1.07 mmol), DMAP (29.1 mg, 0.18 mmol), and HOBt (163.1 mg, 1.07 mmol) were dissolved in a mixed solvent of dry-CH 2 Cl 2 (10 mL) and dry-DMF (5 mL). rice field. After cooling the inside of the system to 0 °C, EDCI (148 µL, 1.07 mmol) was added dropwise and stirred for 20 minutes. Further, the mixture was stirred at room temperature for 28 hours. After completion of the reaction, the system was adjusted to pH 1-2 using 1N HCl aq., and extracted three times with ethyl acetate. The organic layer was washed with saturated brine three times, dehydrated and dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The resulting residue was purified by column chromatography (hexane:ethyl acetate=3:1). (63.9mg, 64%)
Yellow Oil; 1 H NMR (270MHz, CDCl 3 ) δ = 8.53 (s,2H), 8.11(s, 1H), 7.34(s, 5H), 5.11-5.22 (s, 2H), 4.37-4.42 (m, 1H), 3.99-4.04 (m, 1H), 3.59-3.64 (m, 2H), 3.29-3.48 (m, 2H), 2.37-2.46 (m, 1H), 2.03-2.17 (m, 1H), 1.46- 1.51 (t, 2H), 1.25 (s, 16H), 0.85 (t, J = 7.0 Hz, 3H).

(2S,4R)-N-((3,5-Bis(trifluoromethyl)phenyl)sulfonyl)-4-(undecyloxy)pyrrolidine-2-carboxamideの合成 Synthesis of (2S,4R)-N-((3,5-Bis(trifluoromethyl)phenyl)sulfonyl)-4-(undecyloxy)pyrrolidine-2-carbboxamide

Figure 0007244905000015
Figure 0007244905000015

Benzyl (2S,4R)-2-(((3,5-bis(trifluoromethyl)phenyl)sulfonyl)carbamoyl)-4-(undecyloxy)pyrrolidine-1-carboxylate (50.0 mg, 0.07 mmol) を MeOH (600 μL) に溶かし、10% 担持 Pd/C (8.3 mg, 0.007 mmol) を加えた後、H2 置換して室温で 22 時間撹拌した。MeOH を用いてセライトろ過を行い、濾液を減圧濃縮した。(27.6 mg, 68%)
Yellow Oil; 1H NMR (270MHz, CDCl3) δ =8.42 (s, 2H), 7.97 (s, 1H), 4.17 (s, 1H), 3.64-3.35 (m, 4H), 3.09 (s, 1H), 2.68-2.21 (m, 2H), 1.98 (s,2H), 1.53-1.51 (m,2H), 1.25 (s,16H), 0.80 (t, J = 6.5, 3H).
Benzyl (2S,4R)-2-(((3,5-bis(trifluoromethyl)phenyl)sulfonyl)carbamoyl)-4-(undecyloxy)pyrrolidine-1-carboxylate (50.0 mg, 0.07 mmol) in MeOH (600 μL) , 10% supported Pd/C (8.3 mg, 0.007 mmol) was added, replaced with H 2 , and stirred at room temperature for 22 hours. Celite filtration was performed using MeOH, and the filtrate was concentrated under reduced pressure. (27.6mg, 68%)
Yellow Oil; 1 H NMR (270MHz, CDCl 3 ) δ =8.42 (s, 2H), 7.97 (s, 1H), 4.17 (s, 1H), 3.64-3.35 (m, 4H), 3.09 (s, 1H) , 2.68-2.21 (m, 2H), 1.98 (s,2H), 1.53-1.51 (m,2H), 1.25 (s,16H), 0.80 (t, J = 6.5, 3H).

<プロリン触媒(3)の合成>
(2S,4R)-1-((Benzyloxy)carbonyl)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecyl)oxy)pyrrolidine-2-carboxylic acidの合成
<Synthesis of proline catalyst (3)>
(2S,4R)-1-((Benzyloxy)carbonyl)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11 Synthesis of ,11-heptadecafluoroundecyl)oxy)pyrrolidine-2-carboxylic acid

Figure 0007244905000016
Figure 0007244905000016

三ツ口フラスコに (2S,4R)-1-((benzyloxy)carbonyl)-4-hydroxypyrrolidine-2-carboxylic acid (506.4 mg,1.9 mmol) を量りとり、窒素置換した後に dry-DMF (1 mL) を加えた。系内を 0 °C まで冷却した後、水素化ナトリウム (333.3 mg, 5.6 mmol) を 2 回に分けて加え、室温まで昇温して 15 分間攪拌した。系内にDMF (1 mL) に溶かした 1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-heptadecafluoro-11-iodoundecane (2.2 mL, 9.8 mmol) を滴下した後、室温で 90 分間撹拌した。反応終了後、H2O を加え、さらに 1N HCl aq. を用いて系内を pH 1-2 に調製した後、ジエチルエーテルで 3 回抽出した。有機層を飽和食塩水で 3 回洗浄し、無水硫酸ナトリウムで脱水乾燥後、減圧濃縮した。得られた残渣をカラムクロマトグラフィー (ヘキサン : 酢酸エチル = 3 : 1) によって精製した。(631.8 mg, 46%)
Yellow oil; 1H NMR (270 MHz, CDCl3); δ 7.31-7.29 (m, 5H), 5.22-5.08 (m, 2H), 4.49-4.39 (m, 1H), 4.09 (t, J = 3.3 Hz, 1H), 3.71-3.46 (m, 4H), 2.25-2.08 (m, 4H), 1.85-1.61 (m, 2H).
Weigh (2S,4R)-1-((benzyloxy)carbonyl)-4-hydroxypyrrolidine-2-carboxylic acid (506.4 mg, 1.9 mmol) into a three-necked flask, purge with nitrogen, and add dry-DMF (1 mL). rice field. After cooling the inside of the system to 0°C, sodium hydride (333.3 mg, 5.6 mmol) was added in two portions, the temperature was raised to room temperature, and the mixture was stirred for 15 minutes. 1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-heptadecafluoro-11-iodoundecane dissolved in DMF (1 mL) (2.2 mL, 9.8 mmol) was added dropwise and then stirred at room temperature for 90 minutes. After completion of the reaction, H 2 O was added, and the pH of the system was adjusted to 1-2 using 1N HCl aq., followed by extraction with diethyl ether three times. The organic layer was washed with saturated brine three times, dehydrated and dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The resulting residue was purified by column chromatography (hexane:ethyl acetate=3:1). (631.8 mg, 46%)
Yellow oil; 1 H NMR (270 MHz, CDCl 3 ); , 1H), 3.71-3.46 (m, 4H), 2.25-2.08 (m, 4H), 1.85-1.61 (m, 2H).

4-(Trifluoromethyl)benzenesulfonamideの合成 Synthesis of 4-(Trifluoromethyl)benzenesulfonamide

Figure 0007244905000017
Figure 0007244905000017

4-(trifluoromethyl)benzenesulfonyl chloride (500 mg, 2.04 mmol) をH2O (3.2 mL) に溶かした後、25% アンモニア水 (785 μL, 20.4 mmol) を加えて、100 °C で 2 時間撹拌した。減圧濃縮した後、得られた粗生成物に 1N HCl aq. を加え、生じた沈殿物を吸引ろ過により回収した。(386.0 mg, 84%)
White Solid; m.p. 166 -170 °C; 1H NMR (270MHz, CDCl3) δ = 8.04-8.07 (d, J = 8.1, 2H), 7.57-7.59 (d, J = 5.4, 2H), 4.93 (s, 2H).
4-(trifluoromethyl)benzenesulfonyl chloride (500 mg, 2.04 mmol) was dissolved in H 2 O (3.2 mL), 25% aqueous ammonia (785 μL, 20.4 mmol) was added, and the mixture was stirred at 100 °C for 2 hours. . After concentration under reduced pressure, 1N HCl aq. was added to the resulting crude product, and the resulting precipitate was collected by suction filtration. (386.0mg, 84%)
White Solid; mp 166 -170 °C; 1 H NMR (270MHz, CDCl 3 ) δ = 8.04-8.07 (d, J = 8.1, 2H), 7.57-7.59 (d, J = 5.4, 2H), 4.93 (s , 2H).

Benzyl (2S,4R)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecyl)oxy)-2-(((4-(trifluoromethyl)phenyl)sulfonyl)carbamoyl)pyrrolidine-1-carboxylateの合成 Benzyl (2S,4R)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecyl)oxy)- Synthesis of 2-(((4-(trifluoromethyl)phenyl)sulfonyl)carbamoyl)pyrrolidine-1-carboxylate

Figure 0007244905000018
Figure 0007244905000018

N2 雰囲気下にて、(2S, 4R)-1-((benzyloxy)carbonyl)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecyl)oxy)pyrrolidine-2-carboxylic acid (93.2 mg, 0.13 mmol)、4-(trifluoromethyl)benzenesulfonamide (27.2 mg, 0.12 mmol)、および DMAP (46.1 mg, 0.38 mmol) を tBuOH (500 μL) と 1,2-C2H4Cl2 (500 μL) の混合溶媒に溶かした。室温で EDCI (56 μL, 0.32 mmol) を滴下し、28 時間撹拌した。反応終了後、1N HCl aq. を用いて系内を pH 1-2 に調製した後、酢酸エチルで 3 回抽出を行った。有機層を飽和食塩水で 3 回洗浄し、無水硫酸ナトリウムで脱水乾燥後、減圧濃縮した。得られた残渣をカラムクロマトグラフィー (ヘキサン : 酢酸エチル = 1 : 3) によって精製した。(56 mg, 47%)
Yellow oil: 1H NMR (270 MHz, CDCl3); δ 8.14 (d, J = 7.6 Hz, 2H), 7.76 (d, J = 8.1 Hz, 2H), 7.38 (s, 5H), 5.21 (s, 2H), 4.39 (t, J = 6.5 Hz, 1H), 4.01 (t, J = 4.9 1H), 3.62-3.44 (m, 4H), 2.10-1.81 (m, 4H), 0.88 (t, J = 7.3 Hz, 2H).
( 2S , 4R)-1-((benzyloxy)carbonyl)-4-((4,4,5,5,6,6,7,7,8,8,9,9, 10,10,11,11,11-heptadecafluoroundecyl)oxy)pyrrolidine-2-carboxylic acid (93.2 mg, 0.13 mmol), 4-(trifluoromethyl)benzenesulfonamide (27.2 mg, 0.12 mmol), and DMAP (46.1 mg, 0.38 mmol) ) was dissolved in a mixed solvent of t BuOH (500 μL) and 1,2-C 2 H 4 Cl 2 (500 μL). EDCI (56 μL, 0.32 mmol) was added dropwise at room temperature and stirred for 28 hours. After completion of the reaction, the system was adjusted to pH 1-2 using 1N HCl aq., and extracted three times with ethyl acetate. The organic layer was washed with saturated brine three times, dehydrated and dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The resulting residue was purified by column chromatography (hexane:ethyl acetate=1:3). (56mg, 47%)
Yellow oil: 1 H NMR (270 MHz, CDCl 3 ); δ 8.14 (d, J = 7.6 Hz, 2H), 7.76 (d, J = 8.1 Hz, 2H), 7.38 (s, 5H), 5.21 (s, 2H), 4.39 (t, J = 6.5 Hz, 1H), 4.01 (t, J = 4.9 1H), 3.62-3.44 (m, 4H), 2.10-1.81 (m, 4H), 0.88 (t, J = 7.3 Hz, 2H).

(2S,4R)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecyl)oxy)-N-((4-(trifluoromethyl)phenyl)sulfonyl)pyrrolidine-2-carboxamideの合成 (2S,4R)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecyl)oxy)-N Synthesis of -((4-(trifluoromethyl)phenyl)sulfonyl)pyrrolidine-2-carboxamide

Figure 0007244905000019
Figure 0007244905000019

benzyl (2S,4R)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecyl)oxy)-2-(((4-(trifluoromethyl)phenyl)sulfonyl)carbamoyl)pyrrolidine-1-carboxylate (56 mg, 0.06 mmol) を MeOH (1.5 mL) に溶かし、5% 担持 Pd/C (257.6 mg, 0.12 mmol) を加えた後、H2 置換して 50 °C で 15.5 時間撹拌した。MeOH を用いてセライトろ過を行い、濾液を減圧濃縮した。(31.9 mg, 67%)
Yellow Oil; 1H NMR (270MHz, CDCl3) δ = 8.12-8.05 (m, 2H), 7.80-7.65 (m, 2H), 4.32-4.09 (m, 2H), 3.76-3.80 (m, 1H), 3.48-3.40 (m, 4H), 2.87 (s, 1H), 2.45-2.41 (m,1H), 2.14-2.05 (m, 3H), 1.83-1.81 (m, 2H).
benzyl (2S,4R)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecyl)oxy)- 2-(((4-(trifluoromethyl)phenyl)sulfonyl)carbamoyl)pyrrolidine-1-carboxylate (56 mg, 0.06 mmol) was dissolved in MeOH (1.5 mL) and treated with 5% Pd/C (257.6 mg, 0.12 mmol). was added, replaced with H 2 , and stirred at 50 °C for 15.5 hours. Celite filtration was performed using MeOH, and the filtrate was concentrated under reduced pressure. (31.9mg, 67%)
Yellow Oil; 1 H NMR (270MHz, CDCl 3 ) δ = 8.12-8.05 (m, 2H), 7.80-7.65 (m, 2H), 4.32-4.09 (m, 2H), 3.76-3.80 (m, 1H), 3.48-3.40 (m, 4H), 2.87 (s, 1H), 2.45-2.41 (m, 1H), 2.14-2.05 (m, 3H), 1.83-1.81 (m, 2H).

<対照プロリン触媒(1)の合成>
以下に示す対照プロリン触媒(1)は、非特許文献3(Adv. Synth. Catal. 2004, 346, 1141.)に準じて、2位のスルホンアミド部位を構築し、通常のSN2反応を利用して4位のアルキル化を実施した。
<Synthesis of control proline catalyst (1)>
The control proline catalyst (1) shown below constructs the sulfonamide site at the 2-position according to Non-Patent Document 3 (Adv. Synth. Catal. 2004, 346, 1141.) and utilizes the usual SN2 reaction. 4-position alkylation was carried out.

Figure 0007244905000020
Figure 0007244905000020

<対照プロリン触媒(2)の合成>
以下に示す対照プロリン触媒(2)は、非特許文献4(Tetrahedron: Asymmetry 2003, 14, 139.)に準じて合成した。
<Synthesis of control proline catalyst (2)>
The control proline catalyst (2) shown below was synthesized according to Non-Patent Document 4 (Tetrahedron: Asymmetry 2003, 14, 139.).

Figure 0007244905000021
Figure 0007244905000021

本実施例では、合成したプロリン触媒(1)~(3)でアルドール反応を実施した。 In this example, an aldol reaction was carried out using the synthesized proline catalysts (1) to (3).

<プロリン触媒(1)を用いたアルドール反応>
2-(Hydroxy(4-nitrophenyl)methyl)cyclohexan-1-oneの合成
<Aldol reaction using proline catalyst (1)>
Synthesis of 2-(Hydroxy(4-nitrophenyl)methyl)cyclohexan-1-one

Figure 0007244905000022
Figure 0007244905000022

プロリン触媒(1)(5.6 mg, 0.0065 mmol) に H2O (0.66 mL)、シクロヘキサノン (683.5 μL, 6.6 mmol)、およびニトロベンズアルデヒド (100.3 mg, 0.66 mmol) を加え、23 °C で168 時間撹拌した。反応終了後、減圧濃縮して得られた残渣をカラムクロマトグラフィー (ヘキサン : 酢酸エチル = 3 : 1) によって精製した (132.7 mg, 81%)。syn 体と anti 体の生成比は粗生成物の 1H NMR より算出した(anti 体 : syn 体 = 100 : 0)。anti 体のエナンチオマー過剰率は HPLC によって算出した (Daicel Chiralpak IB + OD-3 column, hex : iPrOH = 96 : 4, 1.0 mL/min, >99%ee)。
white solid; m.p. 97.7-98.8 °C; 1H NMR (270 MHz, CDCl3); δ 8.23-8.19 (m, 2H), 7.54-7.50 (m, 2H), 4.91 (dd, J = 2.7, 8.1 Hz, 1H), 4.13 (d, J = 3.0 Hz, 1H), 2.66-2.31 (m, 3H), 2.16-2.05 (m, 1H), 1.85-1.23 (m, 5H).
H 2 O (0.66 mL), cyclohexanone (683.5 μL, 6.6 mmol), and nitrobenzaldehyde (100.3 mg, 0.66 mmol) were added to proline catalyst (1) (5.6 mg, 0.0065 mmol) and stirred at 23 °C for 168 hours. bottom. After completion of the reaction, the residue obtained by concentration under reduced pressure was purified by column chromatography (hexane:ethyl acetate=3:1) (132.7 mg, 81%). The ratio of syn-isomer to anti-isomer was calculated from 1 H NMR of the crude product (anti-isomer:syn-isomer=100:0). The enantiomeric excess of the anti isomer was calculated by HPLC (Daicel Chiralpak IB + OD-3 column, hex : i PrOH = 96 : 4, 1.0 mL/min, >99%ee).
white solid; mp 97.7-98.8 °C; 1 H NMR (270 MHz, CDCl 3 ); , 1H), 4.13 (d, J = 3.0 Hz, 1H), 2.66-2.31 (m, 3H), 2.16-2.05 (m, 1H), 1.85-1.23 (m, 5H).

2-(Hydroxy(4-nitrophenyl)methyl)cyclohexan-1-oneの合成 Synthesis of 2-(Hydroxy(4-nitrophenyl)methyl)cyclohexan-1-one

Figure 0007244905000023
Figure 0007244905000023

プロリン触媒(1)(5.6 mg, 0.0065 mmol) に THF (0.66 mL)、シクロヘキサノン (683.5 μL, 6.6 mmol)、およびニトロベンズアルデヒド (100.3 mg, 0.66 mmol) を加え、23 °Cので 96 時間撹拌した。反応終了後、減圧濃縮して得られた残渣をカラムクロマトグラフィー (ヘキサン : 酢酸エチル = 3 : 1) によって精製した (143.9 mg, 87%)。syn 体と anti 体の生成比は粗生成物の 1H NMR より算出した(anti 体 : syn 体 = 100 : 0)。anti 体のエナンチオマー過剰率は HPLC によって算出した (Daicel Chiralpak IB + OD-3 column, hex : iPrOH = 96 : 4, 1.0 mL/min, >99%ee)。
white solid; m.p. 97.7-98.8 °C; 1H NMR (270 MHz, CDCl3); δ 8.23-8.19 (m, 2H), 7.54-7.50 (m, 2H), 4.91 (dd, J = 2.7, 8.1 Hz, 1H), 4.13 (d, J = 3.0 Hz, 1H), 2.66-2.31 (m, 3H), 2.16-2.05 (m, 1H), 1.85-1.23 (m, 5H).
THF (0.66 mL), cyclohexanone (683.5 μL, 6.6 mmol), and nitrobenzaldehyde (100.3 mg, 0.66 mmol) were added to proline catalyst (1) (5.6 mg, 0.0065 mmol) and stirred at 23 °C for 96 hours. After completion of the reaction, the residue obtained by concentration under reduced pressure was purified by column chromatography (hexane:ethyl acetate=3:1) (143.9 mg, 87%). The ratio of syn-isomer to anti-isomer was calculated from 1 H NMR of the crude product (anti-isomer:syn-isomer=100:0). The enantiomeric excess of the anti isomer was calculated by HPLC (Daicel Chiralpak IB + OD-3 column, hex : i PrOH = 96 : 4, 1.0 mL/min, >99%ee).
white solid; mp 97.7-98.8 °C; 1 H NMR (270 MHz, CDCl 3 ); , 1H), 4.13 (d, J = 3.0 Hz, 1H), 2.66-2.31 (m, 3H), 2.16-2.05 (m, 1H), 1.85-1.23 (m, 5H).

2-(Hydroxy(4-nitrophenyl)methyl)cyclohexan-1-oneの合成 Synthesis of 2-(Hydroxy(4-nitrophenyl)methyl)cyclohexan-1-one

Figure 0007244905000024
Figure 0007244905000024

プロリン触媒(1)(5.6 mg, 0.0065 mmol) に toluene (0.66 mL)、シクロヘキサノン (683.5 μL, 6.6 mmol)、およびニトロベンズアルデヒド (100.1 mg, 0.66 mmol) を加え、23 °Cで 120 時間撹拌した。反応終了後、減圧濃縮して得られた残渣をカラムクロマトグラフィー (ヘキサン: 酢酸エチル = 3 : 1) によって精製した (152.0 mg, 92%)。syn 体と anti 体の生成比は粗生成物の 1H NMR より算出した(anti 体 : syn 体 = 97 : 3)。anti 体のエナンチオマー過剰率は HPLC によって算出した (Daicel Chiralpak IB + OD-3 column, hex : iPrOH = 96 : 4, 1.0 mL/min, >99%ee)。
white solid; m.p. 97.7-98.8 °C; 1H NMR (270 MHz, CDCl3); δ 8.23-8.19 (m, 2H), 7.54-7.50 (m, 2H), 4.91 (dd, J = 2.7, 8.1 Hz, 1H), 4.13 (d, J = 3.0 Hz, 1H), 2.66-2.31 (m, 3H), 2.16-2.05 (m, 1H), 1.85-1.23 (m, 5H).
Toluene (0.66 mL), cyclohexanone (683.5 μL, 6.6 mmol), and nitrobenzaldehyde (100.1 mg, 0.66 mmol) were added to proline catalyst (1) (5.6 mg, 0.0065 mmol) and stirred at 23 °C for 120 hours. After completion of the reaction, the residue obtained by concentration under reduced pressure was purified by column chromatography (hexane:ethyl acetate=3:1) (152.0 mg, 92%). The production ratio of syn-isomer and anti-isomer was calculated from 1 H NMR of the crude product (anti-isomer:syn-isomer=97:3). The enantiomeric excess of the anti isomer was calculated by HPLC (Daicel Chiralpak IB + OD-3 column, hex : i PrOH = 96 : 4, 1.0 mL/min, >99%ee).
white solid; mp 97.7-98.8 °C; 1 H NMR (270 MHz, CDCl 3 ); , 1H), 4.13 (d, J = 3.0 Hz, 1H), 2.66-2.31 (m, 3H), 2.16-2.05 (m, 1H), 1.85-1.23 (m, 5H).

2-(Hydroxy(4-nitrophenyl)methyl)cyclohexan-1-oneの合成 Synthesis of 2-(Hydroxy(4-nitrophenyl)methyl)cyclohexan-1-one

Figure 0007244905000025
Figure 0007244905000025

プロリン触媒(1)(56.3 mg, 0.065 mmol) に toluene (0.66 mL)、シクロヘキサノン (683.5 μL, 6.6 mmol)、およびニトロベンズアルデヒド (100.7 mg, 0.66 mmol) を加え、23 °C で 24 時間撹拌した。反応終了後、減圧濃縮して得られた残渣をカラムクロマトグラフィー (ヘキサン: 酢酸エチル = 3 : 1) によって精製した (155.4 mg, 94%)。syn 体と anti 体の生成比は粗生成物の 1H NMR より算出した(anti 体 : syn 体 = 97 : 3)。anti 体のエナンチオマー過剰率は HPLC によって算出した (Daicel Chiralpak IB + OD-3 column, hex : iPrOH = 96 : 4, 1.0 mL/min, >99%ee)。
white solid; m.p. 97.7-98.8 °C; 1H NMR (270 MHz, CDCl3); δ 8.23-8.19 (m, 2H), 7.54-7.50 (m, 2H), 4.91 (dd, J = 2.7, 8.1 Hz, 1H), 4.13 (d, J = 3.0 Hz, 1H), 2.66-2.31 (m, 3H), 2.16-2.05 (m, 1H), 1.85-1.23 (m, 5H).
Toluene (0.66 mL), cyclohexanone (683.5 μL, 6.6 mmol), and nitrobenzaldehyde (100.7 mg, 0.66 mmol) were added to proline catalyst (1) (56.3 mg, 0.065 mmol) and stirred at 23 °C for 24 hours. After completion of the reaction, the residue obtained by concentration under reduced pressure was purified by column chromatography (hexane:ethyl acetate=3:1) (155.4 mg, 94%). The production ratio of syn-isomer and anti-isomer was calculated from 1 H NMR of the crude product (anti-isomer:syn-isomer=97:3). The enantiomeric excess of the anti isomer was calculated by HPLC (Daicel Chiralpak IB + OD-3 column, hex : i PrOH = 96 : 4, 1.0 mL/min, >99%ee).
white solid; mp 97.7-98.8 °C; 1 H NMR (270 MHz, CDCl 3 ); , 1H), 4.13 (d, J = 3.0 Hz, 1H), 2.66-2.31 (m, 3H), 2.16-2.05 (m, 1H), 1.85-1.23 (m, 5H).

<プロリン触媒(2)を用いたアルドール反応>
2-(Hydroxy(4-nitrophenyl)methyl)cyclohexan-1-oneの合成
<Aldol reaction using proline catalyst (2)>
Synthesis of 2-(Hydroxy(4-nitrophenyl)methyl)cyclohexan-1-one

Figure 0007244905000026
Figure 0007244905000026

プロリン触媒(2)(9.7 mg, 0.017 mmol) に toluene (180 μL)、シクロヘキサノン (170 μL, 1.7 mmol)、ニトロベンズアルデヒド (26.1 mg, 0.17 mmol) を加え、室温で 24 時間撹拌した。減圧濃縮して得られた残渣を 1H NMR 測定することにより、変換率および syn 体と anti 体の生成比を算出した (変換率 = 99%, anti 体 : syn 体 = 100 : 0)。anti 体のエナンチオマー過剰率は HPLC によって算出した (Daicel Chiralpak IB + OD-3 column, hex : iPrOH = 96 : 4, 1.0 mL/min, >99%ee)。 Toluene (180 μL), cyclohexanone (170 μL, 1.7 mmol) and nitrobenzaldehyde (26.1 mg, 0.17 mmol) were added to proline catalyst (2) (9.7 mg, 0.017 mmol) and stirred at room temperature for 24 hours. The residue obtained by concentration under reduced pressure was subjected to 1 H NMR measurement to calculate the conversion rate and the production ratio of syn isomer and anti isomer (conversion rate = 99%, anti isomer: syn isomer = 100:0). The enantiomeric excess of the anti isomer was calculated by HPLC (Daicel Chiralpak IB + OD-3 column, hex : i PrOH = 96 : 4, 1.0 mL/min, >99%ee).

2-(Hydroxy(4-nitrophenyl)methyl)cyclohexan-1-oneの合成 Synthesis of 2-(Hydroxy(4-nitrophenyl)methyl)cyclohexan-1-one

Figure 0007244905000027
Figure 0007244905000027

プロリン触媒(2) (7.4 mg, 0.009 mmol) に toluene (93 μL)、シクロヘキサノン (96 μL, 0.9 mmol)、ニトロベンズアルデヒド (14.6 mg, 0.09 mmol) を加え、室温で 24 時間撹拌した。減圧濃縮して得られた残渣を 1H NMR 測定することにより、変換率および syn 体と anti 体の生成比を算出した (変換率 = 67%, anti 体 : syn 体 = 94 : 6)。anti 体のエナンチオマー過剰率は HPLC によって算出した (Daicel Chiralpak IB + OD-3 column, hex : iPrOH = 96 : 4, 1.0 mL/min, 91%ee)。 Toluene (93 μL), cyclohexanone (96 μL, 0.9 mmol) and nitrobenzaldehyde (14.6 mg, 0.09 mmol) were added to proline catalyst (2) (7.4 mg, 0.009 mmol) and stirred at room temperature for 24 hours. The residue obtained by concentration under reduced pressure was subjected to 1 H NMR measurement to calculate the conversion rate and syn-to-anti-formation ratio (conversion rate = 67%, anti : syn isomer = 94:6). The enantiomeric excess of the anti isomer was calculated by HPLC (Daicel Chiralpak IB + OD-3 column, hex: i PrOH = 96:4, 1.0 mL/min, 91%ee).

なお、対照プロリン触媒(1)及び(2)についても、非特許文献3(Adv. Synth. Catal. 2004, 346, 1141.)に準じて、実施例と同様の基質についてアルドール反応を実施した。 For the control proline catalysts (1) and (2) as well, the aldol reaction was carried out using the same substrates as in Examples according to Non-Patent Document 3 (Adv. Synth. Catal. 2004, 346, 1141.).

Figure 0007244905000028
Figure 0007244905000028

プロリン触媒(1)~(3)及び対照プロリン触媒(1)~(2)の結果を以下に示す。 Results for proline catalysts (1)-(3) and control proline catalysts (1)-(2) are shown below.

Figure 0007244905000029
なお、*は1H NMRによる結果であり、**は、キラルHPLC(Daicel Chiralpack
IB+OD-3 カラム、Hex:iPrOH=96:4、1.0ml/min)による測定結果である。
Figure 0007244905000029
In addition, * is the result by 1 H NMR, ** is chiral HPLC (Daicel Chiralpack
IB+OD-3 column, Hex:iPrOH=96:4, 1.0 ml/min).

表1に示すように、プロリン触媒(1)~(3)によれば、極めて高い光学活性アンチ型のβ-ヒドロキシ化合物を合成することができるとともに、高い収率も同時に得ることができる。 As shown in Table 1, the proline catalysts (1) to (3) make it possible to synthesize extremely high optically active anti-β-hydroxy compounds and to obtain high yields at the same time.

Claims (8)

以下の式(1)で表されるプロリン誘導体若しくはその鏡像体であるプロリン誘導体又はその塩である、アルドール反応用触媒。
Figure 0007244905000030
(R1は、第1のフルオラス基又は炭化水素基を有する第1の置換基を表し、前記第1のフルオラス基は炭素数が4~12個のポリフルオロアルキル基であり、前記第1の炭化水素基は炭素数が4~18個のアルキル基、アリール基又はアラルキル基であり、2は、第2のフルオラス基を有するとともに、ピロリジン骨格の2位の炭素原子にカルボニル基が結合した構造を有する第2の置換基を表す。)
A catalyst for an aldol reaction, which is a proline derivative represented by the following formula (1), a proline derivative that is an enantiomer thereof, or a salt thereof.
Figure 0007244905000030
(R 1 represents a first fluorous group or a first substituent having a hydrocarbon group , the first fluorous group is a polyfluoroalkyl group having 4 to 12 carbon atoms, and the first The hydrocarbon group is an alkyl group, aryl group or aralkyl group having 4 to 18 carbon atoms, and R 2 has a second fluorous group and a carbonyl group bonded to the 2-position carbon atom of the pyrrolidine skeleton. represents the second substituent having the structure .)
前記ポリフルオロアルキル基は、パーフルオロアルキル基である、請求項に記載のアルドール反応用触媒。 2. The aldol reaction catalyst according to claim 1 , wherein said polyfluoroalkyl group is a perfluoroalkyl group. 前記第1の置換基は、アルキレン基を介して、ピロリジン骨格の4位に導入される前記第1のフルオラス基又は炭化水素基を備えている、請求項1又は2に記載のアルドール反応用触媒。 The aldol reaction catalyst according to claim 1 or 2 , wherein the first substituent comprises the first fluorous group or hydrocarbon group introduced at the 4-position of the pyrrolidine skeleton via an alkylene group. . 前記第2のフルオラス基は、炭素数1~4のポリフルオロアルキル基である、請求項1~のいずれかに記載のアルドール反応用触媒。 The aldol reaction catalyst according to any one of claims 1 to 3 , wherein the second fluorous group is a polyfluoroalkyl group having 1 to 4 carbon atoms. 前記ポリフルオロアルキル基は、パーフルオロアルキル基である、請求項に記載のアルドール反応用触媒。 5. The aldol reaction catalyst according to claim 4 , wherein the polyfluoroalkyl group is a perfluoroalkyl group. 前記第2の置換基は、前記カルボニル炭素に結合する窒素原子を含むスルホンアミド部分を介して前記第2のフルオラス基を備える、請求項1~のいずれかに記載のアルドール反応用触媒。 6. The aldol reaction catalyst according to any one of claims 1 to 5 , wherein said second substituent comprises said second fluorous group via a sulfonamide moiety containing a nitrogen atom bonded to said carbonyl carbon. 請求項1~のいずれかに記載のアルドール反応用触媒を用いて、α水素を有するカルボニル化合物とケトン又はアルデヒドとのアルドール反応を行ってβ-ヒドロキシ化合物を合成する工程を備える、β-ヒドロキシ化合物製造方法。 A β-hydroxy compound comprising a step of synthesizing a β-hydroxy compound by performing an aldol reaction between a carbonyl compound having α hydrogen and a ketone or aldehyde using the aldol reaction catalyst according to any one of claims 1 to 6 . A method for producing a compound. 前記α水素を有するカルボニル化合物は、ニトロ基を有する、請求項に記載の製造方法。 The production method according to claim 7 , wherein the carbonyl compound having α-hydrogen has a nitro group.
JP2019032112A 2019-02-25 2019-02-25 Organocatalysts for highly stereoselective asymmetric aldol reactions and their applications Active JP7244905B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019032112A JP7244905B2 (en) 2019-02-25 2019-02-25 Organocatalysts for highly stereoselective asymmetric aldol reactions and their applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2019032112A JP7244905B2 (en) 2019-02-25 2019-02-25 Organocatalysts for highly stereoselective asymmetric aldol reactions and their applications

Publications (2)

Publication Number Publication Date
JP2020131172A JP2020131172A (en) 2020-08-31
JP7244905B2 true JP7244905B2 (en) 2023-03-23

Family

ID=72277216

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019032112A Active JP7244905B2 (en) 2019-02-25 2019-02-25 Organocatalysts for highly stereoselective asymmetric aldol reactions and their applications

Country Status (1)

Country Link
JP (1) JP7244905B2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009114135A (en) 2007-11-07 2009-05-28 Tokyo Univ Of Science Method for producing asymmetric catalyzed aldol reaction product
US20100184986A1 (en) 2007-09-17 2010-07-22 The State of Oregon acting by and through the State Board of Higher Education on behalf of Orego Sulfonamide-based organocatalysts and method for their use
CN103819499A (en) 2014-01-29 2014-05-28 浙江工业大学 Chiral secondary amine containing silica ether structure as well as preparation method and application of chiral secondary amine
JP2015003908A (en) 2013-05-24 2015-01-08 協和発酵バイオ株式会社 Hydroxyproline derivative

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100184986A1 (en) 2007-09-17 2010-07-22 The State of Oregon acting by and through the State Board of Higher Education on behalf of Orego Sulfonamide-based organocatalysts and method for their use
JP2009114135A (en) 2007-11-07 2009-05-28 Tokyo Univ Of Science Method for producing asymmetric catalyzed aldol reaction product
JP2015003908A (en) 2013-05-24 2015-01-08 協和発酵バイオ株式会社 Hydroxyproline derivative
CN103819499A (en) 2014-01-29 2014-05-28 浙江工业大学 Chiral secondary amine containing silica ether structure as well as preparation method and application of chiral secondary amine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEN, W. -B. et al.,Tetrahedron,2009年12月24日,Vol.66,pp.1441-1446,DOI:10.1016/j.tet.2009.12.041
FACHE, F. et al.,Tetrahedron: Asymmetry,2003年,Vol.14,pp.139-143,DOI:10.1016/S0957-4166(02)00796-6
KINSELLA, M. et al.,Tetrahedron: Asymmetry,2011年09月16日,Vol.22,pp.1423-1433,DOI:10.1016/j.tetasy.2011.07.016

Also Published As

Publication number Publication date
JP2020131172A (en) 2020-08-31

Similar Documents

Publication Publication Date Title
Bhowmick et al. Catalytic asymmetric carbon–carbon bond-forming reactions in aqueous media
Wang et al. A novel proline‐valinol thioamide small organic molecule for a highly enantioselective direct aldol reaction
ES2613850T3 (en) Asymmetric synthesis processes for the preparation of aminosulfone compounds
Fotaras et al. A tripeptide-like prolinamide-thiourea as an aldol reaction catalyst
CN1986516A (en) Process for preparing enantiomerically enriched 2-alkoxy-3-phenylpropionic acids
JP6917949B2 (en) An improved method for the preparation of chiral 3-amino-piperidine, a useful intermediate for the preparation of tofacitinib
WO2004060831A1 (en) Method of deuterization
CN111943929B (en) 2,4-diaminopyridine nitroxides as catalysts and their use in the ring opening of azlactone alcohols
JP2015501282A (en) Process for producing optically active β-hydroxy-α-aminocarboxylic acid ester
JP7244905B2 (en) Organocatalysts for highly stereoselective asymmetric aldol reactions and their applications
Brunner et al. Asymmetric catalysis, part 108 copper catalysts with optically active ligands in the enantioselective Meerwein arylation of activated olefins
KR20130090360A (en) Method for preparing compounds through a novel michael-addition reaction using water or various acids as additives
Kajiwara et al. Asymmetric catalytic hydrogenation for large scale preparation of optically active 2-(N-benzoylamino) cyclohexanecarboxylic acid derivatives
WO2008135386A1 (en) Chiral ligands of the n-heterocyclic carbene type for asymmetrical catalysis
JP5004138B2 (en) Process for producing β-hydroxycarbonyl compound
JP4308155B2 (en) Process for producing δ-iminomalonic acid derivative and catalyst therefor
JP5001263B2 (en) Asymmetric hydrogenation for the preparation of diphenylalanine derivatives
KR101020486B1 (en) Novel 1,3-butadien-2-yl methyl amine derivatives and a process for their preparation using indium reagents
JP4860510B2 (en) Production of carboxylic acid having asymmetric point at β-position and nucleophile
JPH0570412A (en) Production of optically active beta-amino alcohol
JP5054686B2 (en) Method for producing ester or alcohol
CN107325025A (en) A kind of chiral alpha amino acid derivativges and preparation method thereof
EP1978016A1 (en) Asymmetric reduction method
JP7427242B2 (en) Optically active azide ester and method for producing the same
JP2003160549A (en) METHOD FOR SYNTHESIZING OPTICALLY ACTIVE beta-ARYLAMIDE

Legal Events

Date Code Title Description
A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20190320

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190416

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20211111

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220816

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220927

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221128

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230228

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230303

R150 Certificate of patent or registration of utility model

Ref document number: 7244905

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150